Easterly Government Properties, Inc. (DEA) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals a stable financial performance with a 6% YoY growth in Core FFO and high occupancy rates. The Q&A indicates optimism about the $1.5 billion pipeline and government efficiency, despite some management ambiguity. The completion of the FDA Atlanta facility and strong acquisition terms in Virginia are positive signs. While economic uncertainties and strategic risks exist, the company's focus on efficiency and partnerships suggests a positive outlook. Given the market cap, a 2%-8% positive stock movement is expected.
Key Financial Performance
Net Income per Share (Q4 2025) $0.10, with no year-over-year change mentioned.
Core FFO per Share (Q4 2025) $0.77, grew by nearly 6% year-over-year due to steady operational performance.
Cash Available for Distribution (Q4 2025) $29.1 million, reflecting steady operational performance.
Net Income per Share (Full Year 2025) $0.29, with no year-over-year change mentioned.
Core FFO per Share (Full Year 2025) $2.99, grew by nearly 3% year-over-year due to steady operational performance.
Cash Available for Distribution (Full Year 2025) $118.8 million, reflecting steady operational performance.
Portfolio Occupancy 97%, near historical highs, reflecting the durability of the tenant base.
Weighted Average Lease Term Roughly a decade, indicating long-term stability.
Acquisition of 3-Asset Portfolio in Virginia $44.5 million, totaling approximately 298,000 square feet, with 2.5% annual rent escalations and a weighted average lease term of 7.5 years. Acquired at a going-in cash cap rate of approximately 11%, attributed to a motivated seller.
Development Projects Includes state crime lab in Fort Myers, Florida (delivery targeted for Q4 2026), U.S. courthouse in Flagstaff, Arizona (delivery expected in Q1 2027), and U.S. Courthouse in Medford, Oregon (delivery in H2 2027).
FDA Atlanta Facility Completed and formally delivered to the government on December 15, 2025, with $138.1 million in lump sum reimbursements received as of December 31, 2025, and an additional $12.6 million received earlier this week.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
FDA Atlanta facility: Completed and formally delivered to the government on December 15, 2025. Received $138.1 million in lump sum reimbursements, with additional $12.6 million received recently and $3 million expected in the next few months.
Acquisition of 3-asset portfolio in Virginia: Acquired for $44.5 million, totaling approximately 298,000 square feet. Leased by the Commonwealth of Virginia with 2.5% annual rent escalations and a weighted average lease term of 7.5 years. Acquisition completed at an 11% cash cap rate.
Portfolio occupancy: Maintained near historical highs at 97% with weighted average lease terms of roughly a decade.
Lease renewals: Renewed 38 leases since IPO, with an average rent spread of 14% and weighted average total renewal term of 15.7 years.
Core FFO growth: Targeting 2% to 3% annual growth, with 2026 guidance midpoint reflecting approximately 3% growth.
Development pipeline: Active projects include state crime lab in Fort Myers, Florida (delivery in Q4 2026), U.S. courthouse in Flagstaff, Arizona (delivery in Q1 2027), and U.S. courthouse in Medford, Oregon (delivery in H2 2027).
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company faces challenges in maintaining its cost of capital amidst fluctuating market conditions. This is critical for ensuring accretive growth and maintaining financial flexibility.
Regulatory Hurdles: The company operates in a highly regulated environment, particularly in its partnerships with federal, state, and local government agencies. Changes in regulations or delays in approvals could impact operations and strategic objectives.
Economic Uncertainties: Economic fluctuations could affect the company's ability to secure favorable lease terms or maintain high occupancy rates, which are currently near historical highs at 97%.
Strategic Execution Risks: The company’s growth strategy relies heavily on disciplined capital allocation and maintaining a robust acquisition pipeline. Any misstep in execution could adversely impact long-term growth and financial performance.
Supply Chain Disruptions: The company is engaged in multiple development projects, including courthouses and laboratories. Supply chain disruptions could delay project completions and increase costs.
Competitive Pressures: The company faces competition in acquiring high-quality assets, particularly in partnerships with state governments. This could impact its ability to secure favorable deals and maintain its growth trajectory.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Core FFO Growth: The company is guiding to approximately 3% core FFO per share growth in 2026, which is above the higher end of their stated 2% to 3% annual growth target. This growth is supported by the delivery of FDA Atlanta, renewal execution, operational efficiencies, and acquisitions.
Development Pipeline: The company has an active development pipeline with key projects progressing well. This includes the state crime lab in Fort Myers, Florida (delivery targeted for Q4 2026), the U.S. courthouse project in Flagstaff, Arizona (delivery expected in Q1 2027), and the U.S. Courthouse in Medford, Oregon (delivery scheduled for the second half of 2027).
Acquisition Strategy: The company plans to deploy $50 million to $100 million in gross development-related investment and $50 million in wholly owned acquisitions during 2026. They are focused on disciplined capital management and acquiring high-quality assets with attractive risk-adjusted returns.
Leverage Objectives: The company is working towards a medium-term leverage objective of approximately 6x cash leverage, which is expected to structurally support lower funding costs while preserving the ability to pursue accretive growth.
Market Trends and Demand: The demand for secure, modern government facilities is expected to increase across all levels of government. The company believes its portfolio is well-positioned to meet this demand, driven by the essential nature of its mission-critical facilities.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you touch on the $1.5 billion pipeline and its near-term opportunities?
A:The company is optimistic about 2026 but notes it is early in the year. They are sorting through a significant number of transactions in the pipeline and are focused on acquiring assets that provide a strong spread to their cost of capital. The balance sheet is in great shape, and the acquisitions and development teams are operating at full speed.
Q:Have there been any conversations with the new GSA administrator about lease structures and government efficiency?
A:The company had a brief interaction with the new GSA administrator. They believe the government is focused on efficiency, understanding capital markets, and public-private partnerships. The company is excited to see how this evolves over the next year.
Q:Can you provide details about the Virginia acquisition and its lease expiration schedule?
A:The Commonwealth of Virginia is the largest tenant, occupying over 50% of the asset across two buildings with lease expirations in 2034 and 2036. The 2027 expiration mentioned is for a small, immaterial space of 2,000 square feet.
Q:What is the current leasing status, and what are the expectations for occupancy rates?
A:The portfolio was 97% leased at the end of Q3 2025. The company expects mid-90s occupancy rates to continue. For 2027 expirations, procurement has started and is progressing well with no concerns.
Q:What is the impact of budget cuts across various government agencies on the company?
A:The company views budget cuts as a move towards government efficiency, which aligns with their strategy of supporting mission-critical work. They believe their portfolio's durability and quality position them well to handle these changes. The company is optimistic about public-private partnerships and sees opportunities in the government's focus on efficiency.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific near-term opportunities within the $1.5 billion pipeline, providing only general optimism and a focus on 2026 and 2027. Additionally, while discussing budget cuts, the response lacked specific details on how these cuts might impact the company's operations or tenant relationships.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Affairs law
Cash leverage
Cole core
Commonwealth Virginia
Cushman Wakefield
Darrell Crate
Demand mission
Director Investor
FFO acquisition
Florida building
GSA Mr
GSA Senate
Goldman Sachs
administrator
approach
backdrop
commitment
core mission
decade
demand
diversification
durability tenant
excess
flow capital
funding
government agency
government facility
law enforcement
lease rent
midpoint
mission facility
mission work
objective
occupancy
platform
role
sector
state agency
visibility
DEA Transcript
Easterly Government Properties, Inc. (DEA) Q4 2025 Earnings Call Transcript
Positive2-23
The earnings call reveals a stable financial performance with a 6% YoY growth in Core FFO and high occupancy rates. The Q&A indicates optimism about the $1.5 billion pipeline and government efficiency, despite some management ambiguity. The completion of the FDA Atlanta facility and strong acquisition terms in Virginia are positive signs. While economic uncertainties and strategic risks exist, the company's focus on efficiency and partnerships suggests a positive outlook. Given the market cap, a 2%-8% positive stock movement is expected.
Easterly Government Properties, Inc. (DEA) Q3 2025 Earnings Call Transcript
Positive10-27
The earnings call highlights strong financial performance with growth in Core FFO and reduced cash leverage. The development pipeline is progressing well, and the company maintains a stable liquidity position. Despite some delays in project completion, management's strategic focus on disciplined capital allocation and leveraging partnerships is positive. The reaffirmed investment-grade rating and steady shareholder return plan further support a positive outlook. Market cap suggests moderate reaction potential, hence a positive sentiment with a likely stock price increase of 2% to 8%.
Easterly Government Properties, Inc. (DEA) Q2 2025 Earnings Call Transcript
Unknown8-5
The earnings call shows steady financial performance and strategic positioning, with a 3% core FFO increase and reduced lease exposure. However, the dividend reset and cost of capital challenges create headwinds. The Q&A reveals a strong pipeline but also highlights capital structure concerns. Given the moderate market cap, these mixed signals suggest a neutral stock price movement in the short term.
Easterly Government Properties, Inc. (DEA) Q1 2025 Earnings Call Transcript
Unknown4-29
The earnings call reveals a negative sentiment due to the dividend reduction, which typically affects stock prices negatively. The Q&A section highlights unclear management responses and uncertainties about acquisitions, which can further erode investor confidence. While there are positive elements such as increased borrowing capacity and a strong acquisition pipeline, these are overshadowed by the dividend cut and management's evasiveness on key issues. Considering the company's small market cap, these factors suggest a negative stock price movement in the short term.
DEA Slides
DEA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
